Early Markers for Breast Cancer Detection
Welcome to the EMBED Study – a study looking for early blood markers for breast cancer detection.
We have developed some very sensitive tests that have the potential to detect very small concentrations of a specific blood-marker (circulating tumour DNA) in the blood of women with early stage breast cancer.
If these tests are able to detect breast cancer in its earliest stages, they could eventually be used in clinical settings, such as doctor’s surgeries and hospital settings, to screen for the disease.
On these pages you will find information about the study, details of how you can get involved, links to the online forms and how to get in touch.
If you are a patient and would like to find out more about taking part click here.
If you are a NHS Trust and would like to find out what is involved click here.
If you would like to get in touch follow this link here
The EMBED study is funded through Cancer Research UK and supported by NHS Cambridge University Hospitals, the University of Cambridge and the National Institute for Health Research (NIHR) – Cancer Division.
